NCT04591028View on ClinicalTrials.gov

A Study to Evaluate Indocyanine Green Lymphangiography to Improve Lymphadenectomy in Gastric Cancer Patients

PHASE4WithdrawnINTERVENTIONAL

0

Timeline

Start Date

January 31, 2022

Primary Completion Date

January 31, 2022

Study Completion Date

August 10, 2022

Conditions

Gastric Cancer

Interventions

DRUG

Indocyanine green

A one time injection of IDC prior to the day of scheduled surgery.

Trial Locations (1)

32224

Mayo Clinic in Florida, Jacksonville

Sponsors

Lead Sponsor

All Listed Sponsors

lead

Mayo Clinic

OTHER